David R. Liu: Can we cure genetic diseases by rewriting DNA?
劉如謙博士: 我們可以透過重寫 DNA 治癒遺傳性疾病嗎?
David R. Liu leads a research group that combines chemistry and evolutionary techniques to create revolutionary new medicines. Full bio
Double-click the English transcript below to play the video.
your mother and father ever gave you
of three billion letters of DNA
with three billion components,
組成的東西一樣,
made by your cells,
or base, such as C,
such as T, G or A.
will collectively accumulate
全部加起來累積有
which are also called "point mutations."
亦稱為「點突變」。
point mutations are harmless.
an important capability in a cell
某個重要功能,
in harmful ways.
from your parents
in your development,
that many or all of your cells
你很多或所有的細胞
of hundreds of millions of people
or Tay-Sachs disease.
或精神性痴呆症。
caused by point mutations
令人痛苦的基因型疾病
the exact single-letter change
是哪一個字母的改變
and, in theory, could cure the disease.
鐮刀型紅血球疾病之苦,
a single A to T point mutations
are born with a T
that these wonderful, bright kids
這些美好、聰明的孩子,
by about age 14.
大約在十四歲時就會過世。
to efficiently correct point mutations
T back into a C.
in developing such a capability,
成功開發了這種能力,
鹼基編輯的故事,
as sources of infection,
prone to being infected,
to fight viral infection.
來對抗病毒感染。
is now better known as CRISPR.
CRISPR 防禦機制。
is this purple protein
就是這個紫色的蛋白質,
scissors to cut DNA,
可以剪斷 DNA,
between bacterial and viral DNA,
細菌和病毒 DNA 的不同,
defense system.
programmed to search for,
a virus for the first time,
of that virus's DNA
to direct the CRISPR scissors
during a future infection.
該病毒的 DNA 序列。
the function of the cut viral gene,
會打亂它的基因功能,
the virus's life cycle.
Emmanuelle Charpentier, George Church,
卡彭蒂耶、喬治丘奇、
could be programmed
透過編程讓 CRISPR 剪刀
chosen by bacteria.
病毒 DNA 序列取代掉。
of the cut gene, typically,
of random mixtures of DNA letters
useful for some applications.
that cause genetic diseases,
基因型疾病的點突變,
won't benefit patients,
對病人並沒有益處,
needs to be restored,
必須要被恢復,
already-mutated hemoglobin gene
紅血球疾病的血紅素基因,
to make healthy red blood cells.
製造健康紅血球的能力。
new DNA sequences into cells
DNA 序列放入細胞中,
surrounding a cut site,
in most types of cells,
在大部分類型的細胞中行不通,
still predominate.
I've dreamed of a future
我也夢想在未來
or maybe even cure
to fix point mutations,
人類基因型疾病的成因,
working with my students
和我的學生合作,
directly on an individual DNA base,
個別 DNA 鹼基進行化學反應,
the mutations that cause genetic diseases.
導致遺傳疾病的突變。
are molecular machines
searching mechanism of CRISPR scissors,
可編程搜尋機制,
one base to another base
轉換成另一個鹼基,
CRISPR proteins as molecular scissors,
CRISPR 蛋白質視為分子剪刀,
one DNA letter into another
the atoms of one DNA base
DNA 鹼基的原子,
the first base editor, shown here,
鹼基編輯器,在這裡可以看到,
from the same organism.
來自同一個有機體。
and disabling the ability to cut DNA
讓它失去剪斷 DNA 的能力,
and bind a target DNA sequence
scissors, shown in blue,
能力的 CRISPR 剪刀,
蛋白質,用紅色標示,
on the DNA base C,
發生化學反應,
that behaves like T.
行為類似 T 的鹼基。
to the first two proteins
我們還要再加上
from being removed by the cell.
不會被細胞給移除。
three-part protein
人造的三部件融合蛋白質,
allows us to convert Cs into Ts
將 C 轉換成 T 的蛋白質。
our work was only half done.
我們的工作也才完成一半。
have to form base pairs.
必須要形成鹼基對。
on one DNA strand creates a mismatch,
會造成無法配對的狀況,
by deciding which strand to replace.
必須選擇一股來替換。
this three-part protein
將這個三部件融合蛋白質再改造,
as the one to be replaced
標記為要被取代的目標,
of what used to be a C-G base pair
將原本的 C-G 配對
艾莉西斯•柯摩爾領軍,
in the lab, Alexis Komor,
this first class of base editor,
第一類鹼基編輯器,
將 G 轉換為 A。
disease-associated point mutations,
和疾病相關的點突變中,
that this first base editor can reverse
逆轉其中兩類突變,
or 5,000 or so pathogenic point mutations.
(14%)點突變疾病。
of disease-causing point mutations
造成疾病的點突變,
a second class of base editor,
As into Gs or Ts into Cs.
將 T 轉換為 C。
a former post doc in the lab,
this second class of base editor,
準備開發第二類鹼基編輯器,
almost half of pathogenic point mutations,
一半以上的點突變疾病。
the rapid-aging disease progeria.
borrow, once again,
to the right site in a genome.
定位到基因組的特定位置。
an incredible problem;
A into G or T into C
look for another project,
of a naturally occurring protein
our own protein in the laboratory
that behaves like G,
有 G 行為表現的蛋白質 ,
that performs related chemistry on RNA.
類似化學表現的蛋白質著手。
survival-of-the-fittest selection system
達爾文適者生存的選擇系統,
of protein variants
蛋白質存活下來。
chemistry to survive.
scissors, shown in blue,
用藍色顯示,
strand-nicking strategy
運用的策略,
the nonedited T with a C
of an A-T base pair to a G-C base pair.
轉換成 GC 鹼基的過程。
interrupted by applause.
被掌聲中斷。
first two classes of base editors
鹼基編輯器,
and one and a half years ago.
另一個在一年半之前。
by the biomedical research community.
被廣泛運用了。
more than 6,000 times
應全球一千多位研究人員的索取,
1,000 researchers around the globe.
have been published already,
運用鹼基編輯器的
已經陸陸續續發佈了,
ranging from bacteria
老鼠到靈長類動物都有。
human clinical trials,
a critical milestone towards that goal
that cause human genetic diseases.
點突變校正回來。
led by Luke Koblan and Jon Levy,
組成科研團隊,共同參與合作,
that second base editor
將第二鹼基編輯器
T back into a C
at the DNA, RNA and protein levels.
DNA、RNA和蛋白質狀態。
been used in animals
correcting a point mutation
single DNA letter changes
to probe the role of individual letters
例如癌症疾病基因。
with diseases such as cancer.
Beam Therapeutics and Pairwise Plants,
Beam Therapeutics 和 Pairwise Plants,
to treat human genetic diseases
治療人類的基因型疾病
發生在過去不到三年的時間裡:
than the past three years:
僅僅是眨眼之間。
its full potential
with genetic diseases.
are thought to be treatable
of cells in an organ,
like base editors
to deliver base editors
that give you a cold
delivery strategies
new molecular machines
to another base pair
at off-target locations in cells
doctors, ethicists and governments
倫理學家、政府的參與也很重要,
that base editing is applied thoughtfully,
應用鹼基編輯技術,
even just five years ago
molecular machines
設計出來的分子機器,
an individual base pair
in the human genome
of other outcomes,
執行還原。
are you reading?"
group of students
勤奮努力的學生們,
what we could design ourselves
透過基因工程設計我們自己。
to evolve what we couldn't,
我們所辦不到的事,
that science-fiction-like aspiration
科幻小說裡渴望的夢想
we give our children
three billion letters of DNA,
and repair them.
ABOUT THE SPEAKER
David R. Liu - Chemical biologistDavid R. Liu leads a research group that combines chemistry and evolutionary techniques to create revolutionary new medicines.
Why you should listen
During his PhD research at Berkeley, David R. Liu initiated the first general effort to expand the genetic code in living cells. As a professor at Harvard and the Broad Institute, Liu integrates chemistry and evolution to illuminate biology and develop next-generation therapeutics. He has published more than 170 papers and is an inventor on more than 65 issued US patents.
Liu's major research interests include development and use of genome editing technologies to study and treat genetic diseases; the evolution of proteins with novel therapeutic potential; and the discovery of bioactive synthetic molecules using DNA-encoded libraries. Base editing, phage-assisted continuous evolution (PACE) and DNA-encoded libraries are three technologies pioneered in his laboratory that are now widely used in the biomedical sciences. Liu has also cofounded six biotechnology and therapeutics companies, including Editas Medicine, Beam Therapeutics, Pairwise Plants and Exo Therapeutics.
Liu grew up in Riverside, California, where playing with insects in his backyard crystallized his interest in science. He also is passionate about photography and has been banned from playing blackjack at virtually every major casino in Las Vegas after developing a creative and highly advantageous card-counting system.
David R. Liu | Speaker | TED.com